CompletedNCT01170117
Olanzapine Compared With Placebo for Anorexia Nervosa
About this title
Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
Read the official source — NCT01170117Medication studyAges 18–75United States + CanadaEating disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
What did participation involve?
Depending on the group, the protocol specifies the study medication (olanzapine) or a placebo (an inactive comparison treatment).
- Listed locations
- Baltimore and 4 more locationsSee all locations and recruitment
Study information
Study start dateStarted: August 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 152
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States, Canada
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT01170117
- Official title
Show the full official title
Olanzapine vs Placebo for Outpatients With Anorexia Nervosa
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore, United States · New York, United States · White Plains, United States
2 more locations
- Pittsburgh, United States
- Toronto, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine and Placebo.
Who was this study for?
Listed age limits: 18 years to 75 years.
